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The open reading frame of a Brazilian bovine viral diarrhea virus (BVDV) strain, IBSP4ncp,
was  recombined with the untranslated regions of the reference NADL strain by homologous
recombination in Saccharomyces cerevisiae, resulting in chimeric full-length cDNA clones of
BVDV (chi-NADL/IBSP4ncp#2 and chi-NADL/IBSP4ncp#3). The recombinant clones were suc-
cessfully recovered, resulting in viable viruses, having the kinetics of replication, focus size,
and morphology similar to those of the parental virus, IBSP4ncp. In addition, the chimeric
viruses remained stable for at least 10 passages in cell culture, maintaining their replication
efﬁciency unaltered. Nucleotide sequencing revealed a few point mutations; nevertheless,
the phenotype of the rescued viruses was nearly identical to that of the parental virus in
all  experiments. Thus, genetic stability of the chimeric clones and their phenotypic similar-
ity  to the parental virus conﬁrm the ability of the yeast-based homologous recombination
to  maintain characteristics of the parental virus from which the recombinant viruses were
derived. The data also support possible use of the yeast system for the manipulation of the
BVDV genome.© 2016 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda. This is
s arti
viruses containing a single-stranded, positive-sense RNAan  open acces
ntroductionovine viral diarrhea virus (BVDV) is an important pathogen
f cattle, belonging to the genus Pestivirus in the family
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genome of approximately 12.3 kb. The BVDV RNA genome
contains a single, long open reading frame (ORF) encoding
a polyprotein of approximately 4000 amino acids.1 The
lsevier Editora Ltda. This is an open access article under the CC
.
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ORF is ﬂanked by 5′ and 3′ untranslated regions (UTRs) of
approximately 385 and 229 nucleotides (nt), respectively.2
The viral RNA genome is uncapped at its 5′ end, and trans-
lation by host-cell ribosomes occurs through recognition of
the internal ribosomal entry site (IRES), a tertiary structure
located within the 5′ UTR. Direct translation of the viral
genome gives rise to a polyprotein that is cleaved by cellular
and viral-encoded proteases, resulting in following proteins:
NH2–(Npro–C–Erns–E1–E2–p7–NS2/3–NS4A–NS4B–NS5A–NS5B)–
COOH.1
Field BVDV isolates are classiﬁed into two genotypes,
BVDV-1 and BVDV-2, based on the differences in the 5′ UTR
and on the diversity of glycoprotein E2.3 In addition to the
recognized species, an additional Pestivirus species have been
proposed: Hobi-like or BVDV-3.4 Most ﬁeld isolates of both
genotypes are non-cytopathic (ncp) for cultured cells. Non-
cytopathic isolates are responsible for most infections in the
ﬁeld and are associated with the main clinical and reproduc-
tive consequences of BVDV infection.5
The development of reverse genetics tools for pestiviruses
in the late 1990s facilitated studies concerning many  aspects
of BVDV biology6 and its interactions with the host,7 as well
as the development of vaccine strategies.8 After the pioneer
description of a recombinant cDNA clone of the pestivirus
classical swine fever virus by Moormann et al.9 and the ﬁrst
BVDV clone (CP7) by Meyers et al.10 in 1996, a number of BVDV
cDNA clones have been constructed, including NADL, Oregon,
SD-1, NY’93, Pec515, and 890,11–13 among others. Molecular
strategies to generate infectious BVDV from cDNA were mainly
derived from the classical method described for ﬂaviviruses
by Rice et al.,14 based on the assembly of full-genome-length
cDNA in bacterial plasmid vectors. Instability of full-length
pestiviruses cDNA in bacterial hosts has been partially over-
come by the use of low-copy-number plasmids, but not yet
solved.13,15,16 To improve this system, a bacterial artiﬁcial
chromosome strategy (BAC) was used to generate full-length
cDNA copy of pestiviruses, which seemed to be more  stable
during passages in Escherichia coli.17–19
This study describes the construction of chimeric BVDV
cDNA clones by homologous recombination in yeast (Saccha-
romyces cerevisiae). This strategy has several applications and
has been used, in particular, to overcome the problem of insta-
bility of some ﬂavivirus cDNA clones in E. coli.20 Using this
easy and simple method, chimeric full-length cDNA clones
Table 1 – Oligonucleotides used on the construction of the reco
homologous recombination.
Oligonucleotide 
1 – BVDVqm 5′UTR NADL IBSP4-Fa
2 – BVDV-Osloss-4458Rb
3 – BVDV1-4121F 
4 – BVDV1-8893R 
5 – BVDV-Osloss-8520F 
6 – BVDVqm 3′UTR NADL IBSP4-R 
Oligonucleotides are identiﬁed according to the sequences they amplify/p
a F –sense.
b R – antisense. b i o l o g y 4 7 (2 0 1 6) 993–999
containing the 5′ and 3′ UTRs of the BVDV-1 reference strain
NADL and the entire ORF of a representative Brazilian BVDV-1
strain, IBSP4ncp,21 were successfully constructed through just
one-step assembly.
Materials  and  methods
Cells  and  viruses
Pestivirus-free Madin-Darby bovine kidney (MDBK) cells (ATCC
CCL-22) were used for all viral manipulation procedures.
Cells were maintained in minimal essential medium (MEM,
Sigma–Aldrich, St. Louis, MO, USA) supplemented with 10%
equine serum, 1% penicillin (10,000 UI/mL stock), and strepto-
mycin (10,000 g/mL stock) (Gibco, Langley, OK,  USA) at 37 ◦C,
5% CO2. MDBK cells were monitored for pestiviruses contam-
ination by indirect ﬂuorescent antibody assay (as described in
Section ‘Fluorescent antibody and peroxidase assays’) before
and during all the experiments. The virus used for the con-
struction was a Brazilian non-cytopathic BVDV-1b strain,
IBSP4ncp (GenBank accession number KJ620017).22
Oligonucleotides  and  plasmid  vector
Oligonucleotides for ampliﬁcation and homologous recombi-
nation (Table 1) were initially designed based on the sequences
of conserved regions of reference BVDV-1 strains, available in
the GenBank. The sequences were aligned using ClustalW2
(http://www.ebi.ac.uk/Tools/msa/clustalw2/). Additionally,
some oligonucleotides were designed to add 25 nt to the
termini of amplicons for homologous recombination in yeast
(Table 1). The yeast/E. coli shuttle vector pBSC NADL HDR  con-
taining the whole genome of the BVDV reference strain NADL
was kindly provided by Dr. Ruben O. Donis (CDC Inﬂuenza
Division, Atlanta, GA, USA).
Fluorescent  antibody  and  peroxidase  assays
An indirect ﬂuorescent antibody (IFA) assay was performed
using MDBK cells deposited over glass coverslips. Acetone-
ﬁxed cells were incubated for 1 h at 37 ◦C with a pool of
monoclonal antibodies (MAbs) to BVDV (15c5, 12g4, and
20.10.6),23 followed by washing in phosphate-buffered saline
mbinant cDNA clone of BVDV strain IBSP4ncp by
Sequence
CTAAAAATCTCTGCTGTACATGGCACATGGAGTTGATTGCAAATGAAC
TGAGGGGCAAGAGTATGCTGAC
ACYATMCCRAACTGGAGRCCAC
CATCTCATAGCCACATGGGCAC
TTGAAGCAGTYCAGACAATTGG
ATTTATTTACAATATATACATTTTGTCTCAACTGCTGGCACCGACAG
ossess. The homologous sequences for recombination are in bold.
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PBS) and incubation with an anti-mouse IgG ﬂuorescein
sothiocyanate-conjugated secondary antibody (1:100 in PBS;
igma–Aldrich). Slides were examined under ultraviolet light
n a DMI  4000B ﬂuorescence microscope (Leica, Wetzlar, Ger-
any). Immunoperoxidase (IPX) staining for BVDV antigens
as performed using cell monolayers grown in six-well plates
nd inoculated the respective viruses. Cell monolayers were
xed in 30% cold acetone by 13 min  and incubated with the
ame MAbs for IFA (1 h at 37 ◦C), washed, and incubated with
n anti-mouse horseradish peroxidase (HRP)-conjugated anti-
ody (1:1000 in PBS; Sigma–Aldrich). After washing, an HRP
ubstrate (aminoethylcarbazole – AEC, in acetate buffer 50 mM
 pH 5.0 and hydrogen peroxide 0.2%) was added and incu-
ated for approximately 30 min  at 37 ◦C.
onstruction  of  BVDV  cDNA  clones  by  homologous
ecombination  in  yeast
ecombinant cDNA clones, pBSC IBSP4ncp, were constructed
y homologous recombination in yeast using three reverse
ranscription-polymerase chain reaction (RT-PCR) products
ncompassing the IBSP4ncp ORF and a BamHI-digested
BSC NADL HDR vector. After the digestion, the NADL 5′ and
′ UTRs in the vector remained intact. The strategy of cloning
s depicted in Fig. 1.
mpliﬁcation  of  the  IBSP4ncp  ORF
iral RNA was extracted from the supernatant of MDBK cells
nfected with the IBSP4ncp BVDV strain, using the QIAamp
iral RNA Mini Kit (Qiagen, Valencia, CA, USA). RT was per-
ormed in a 20-L reaction using 50 ng of the RNA template
nd 200 U of Superscript III Reverse Transcriptase (Invitrogen,
arlsbad, CA, USA). The cDNA was ampliﬁed with KlenTaq-LA
olymerase (Clontech, Mountain View, CA, USA). The entire
BSP4ncp ORF was PCR-ampliﬁed in three fragments. The ﬁrst
CR fragment (4081 bp) was ampliﬁed with oligonucleotides 1
nd 2, the second fragment (4466 bp) was ampliﬁed with oligos
 and 4, and the third fragment (3360 bp) was ampliﬁed with
ligos 5 and 6 (Table 1). The PCR conditions were as follows:
nitial denaturation at 95 ◦C for 5 min, 35 cycles (denaturation
t 95 ◦C for 30 s, annealing at 52 ◦C for 30 s, and extension at
2 ◦C for 1 min  for each 1000 bp), and ﬁnal extension at 72 ◦C
or 10 min.
A
B
C
5’UTR
5’UTR
25 nt
325 nt
Sequences remaining in vector
after digestion
pBSC_NADL_HDR digested
74 nt
Npro
Fragment 1
4.081 nt
Fragm
4.46
c Erns E1 E2 p7 NS2-3
IBSP4nc
ig. 1 – Representation of the strategy of construction of the chim
rganization of BVDV IBSP4ncp. (B). Homologous recombination 
C). BamHI digested pBSC NADL HDR vector.o l o g y 4 7 (2 0 1 6) 993–999 995
Yeast  transformation  and  identiﬁcation  of  recombinant
clones
The plasmid pBSC NADL HDR was digested with BamHI (New
England BioLabs, Ipswich, MA, USA) to remove the NADL ORF,
leaving intact the 5′ and 3′ UTRs (Fig. 1), followed by dephos-
phorylation with 5 U of calf-intestinal alkaline phosphatase
(New England BioLabs). The three PCR products correspond-
ing to the whole IBSP4ncp ORF plus the BamHI-digested vector
pBSC-NADL-HDR were introduced simultaneously into the
yeast S. cerevisiae strain RFY206 using the lithium acetate
method.24 After transformation, yeast cells were inoculated
in YNB solid medium (Yeast Nitrogen Base – Sigma–Aldrich)
without tryptophan and maintained at 30 ◦C for up to three
days. Five recombinant yeast colonies were chosen, picked
and ampliﬁed in YNB medium. Plasmid DNA was extracted
from yeast spheroplast pellets using QIAprep Spin MiniPrep
kit (Qiagen). The presence of cloned fragments was conﬁrmed
by PCR, followed by nucleotide sequencing. After the conﬁrma-
tion, two  in three recombinant clones (pBSC IBSP4ncp#2 and
pBSC IBSP4ncp#3) were further ampliﬁed and characterized.
Nucleotide  sequencing
The constructed cDNA clones, pBSC IBSP4ncp#2 and #3, and
full-length PCR products obtained from both clones were
submitted for complete nucleotide sequencing. The parental
virus IBSP4ncp and a chimeric virus, chi-NADL/IBSP4ncp#2,
derived from the corresponding pBSC IBSP4ncp#2 cDNA clone
and recovered at passages 0 (p0, rescued virus) and p5
were submitted for nucleotide sequencing of the whole
genomes. All viral sequences were ampliﬁed from super-
natant of infected cells. Sequencing reactions were performed
using the mix  BigDye® Terminator v3.1 Cycle Sequencing Kit
(Applied Biosystems) according to the manufacturer. Products
of sequencing were resolved in an ABI 3100 Genetic Analyzer
sequencer (Applied Biosystems). Sequence analyses were con-
ducted by using the package Lasergene® (DNAstar Inc.) and a
consensus sequence of each virus was generated by the pro-
gram SeqMan II (Lasergene®, DNAstar Inc.).Full-genome  PCR  ampliﬁcation  and  in  vitro  transcription
A PCR was performed to amplify and linearize the
entire genomes of the chimeric viruses including the
Homologous sequences overlapping fragments
Sequences of the IBSP4ncp genome
 with BamHI
251 nt 25 nt
ent 2
6 nt
Fragment 3
3.360 nt
836 nt
p
NS4A NS4B NS5A NS5B
3’UTR
3’UTR
eric cDNA clones of BVDV strain IBSP4ncp. (A). Genome
in yeast of three PCR products (fragments 1, 2 and 3) and
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sequence of the bacteriophage T7 RNA polymerase
promoter for in vitro transcription. For PCR ampliﬁca-
tion, the reaction mixture contained 100 ng of DNA of
a recombinant clone (pBSC IBSP4ncp#2 or #3), 1 U of
KlenTaq-LA DNA polymerase mix  (Clontech), 0.5 U of Vent
DNA polymerase (Sigma–Aldrich), and oligonucleotides
(pBSC-T7-NADL-F and NADL-3′UTR-R, Table 1). The PCR
products were phenol-chloroform-extracted and ethanol-
precipitated prior to performing in vitro transcription
using the MEGAscript® T7 kit (Ambion, Foster City, CA,
USA).
Transfection  and  monitoring  of  infectivity  of
in vitro-transcribed  RNAs
For transfection, MDBK cells were trypsinized, washed
with serum-free MEM,  then washed twice with PBS,
pH 7.2/diethylpyrocarbonate at 4 ◦C, and resuspended at
8 × 106 cells/mL in 400 L of Cytomix (120 mM KCl, 0.15 mM
CaCl2, 10 mM K2HPO4/KH2PO4, 25 mM HEPES, 2 mM EGTA,
5 mM MgCl2, 2 mM ATP, 5 mM glutathione, and pH adjusted
to 7.6 with KOH). Electroporation was performed using 5 g
of transcribed RNA as described by Qu et al.25 Cell cultures
were maintained for three days and monitored daily for BVDV
antigens by the IFA assay. The presence of infectious virus in
the supernatants of the transfected MDBK cultures was con-
ﬁrmed by inoculating fresh MDBK cell cultures with aliquots of
the supernatants, followed by the IFA assay 72 h later. Viruses
recovered from the supernatants of the transfected cells were
designated chi-NADL/IBSP4ncp#2 and chi-NADL/IBSP4ncp#3,
passage 0 (p0).
Characterization  of  viruses  derived  from  cDNA  clones
Infectivity  and  stability  in  cell  culture
The chimeric viruses (chi-NADL/IBSP4ncp#2 and chi-
NADL/IBSP4ncp#3) were subjected to 10 passages in MDBK
cells. Cells were inoculated with the viruses at a multiplicity of
infection (MOI) of 0.5 for each passage and incubated at 37 ◦C,
5% CO2 for 72 h. At the end of each passage, the supernatants
were tested by the IFA assay, and virus quantiﬁcation was
performed by a plaque assay.
Kinetics  of  virus  replication  and  focus  assays
The viruses chi-NADL/IBSP4ncp#2 and #3 at p5 and the
parental virus IBSP4ncp were individually inoculated into
MDBK cell cultures at an MOI  of 0.3 each. The inoculum
was removed, and the cell monolayers were washed with
MEM,  followed by the addition of fresh culture medium and
incubation at 37 ◦C, 5% CO2. Aliquots of the culture super-
natants were harvested at different times (0, 8, 16, 24, 32, 40,
48, 56, 64, and 72 h), and viruses were quantiﬁed by limiting
dilution. To examine the size and morphology of infectious
foci produced by the recombinant viruses at p5 and by the
parental virus IBSP4ncp, 90% conﬂuent MDBK cell monolayers
grown in six-well plates were inoculated with viral dilutions
(10−1 to 10−7). After 1 h adsorption at 37 ◦C, the viral inocu-
lum was removed, and the cell monolayers were washed, b i o l o g y 4 7 (2 0 1 6) 993–999
overlaid with 1% agarose in MEM plus 5% equine serum,
and incubated at 37 ◦C, 5% CO2. After 72 h, the monolay-
ers were ﬁxed and subjected to IPX staining as described
above.
Stability  of  recombinant  yeast  cDNA  clones  in  E.  coli
The recombinant plasmids pBSC IBSP4ncp#2 and #3 were
electroporated into E. coli DH10B (Invitrogen) using an ECM
830 BTX electroporator. The electroporation conditions were
as follows: 2.75 kV, 99 s, 5 pulses, and 1 s between pulses.
Colonies were grown at 37 ◦C in Luria-Bertani medium with
chloramphenicol (20 g/mL) at 37 ◦C for 18–20 h. Plasmid DNA
was then puriﬁed with the QIAGEN Plasmid Midi Kit  (Qiagen)
and used as a template for in vitro transcription. MDBK cells
were electroporated with the RNA as described above. Infec-
tivity of the RNA was accessed by the IFA assay performed
at 24, 48, and 72 h after the transfection. Progeny viruses
were harvested and subjected to ﬁve passages in MDBK cells,
with the infectivity monitored at each passage by the IFA
assay.
Results
Construction  of  chimeric  NADL-IBSP4ncp  cDNA  clones
Recombinant cDNA clones containing the entire ORF of the
Brazilian BVDV strain IBSP4ncp and the UTRs of the NADL
strain were successfully constructed by homologous recombi-
nation in yeast. The correct recombination of the NADL UTRs
and the IBSP4ncp ORF was conﬁrmed by nucleotide sequenc-
ing of the UTR-ORF junctions. Two recombinant viruses were
recovered for further characterization (chi-NADL/IBSP4ncp#2
and chi-NADL/IBSP4ncp#3).
Infectivity  and  stability  of  RNA  transcribed  in  vitro  from
recombinant  cDNA  clones
To access the infectivity of RNA derived from the cloned BVDV
genome, the plasmid DNA of the clones pBSC IBSP4ncp#2
and #3, isolated from yeast cells, was initially subjected to
a PCR encompassing the entire viral genome. The ampli-
cons were used as templates for in vitro transcription, and
the transcribed RNAs were then used for transfection of
MDBK cells. Viral antigens were detected in the MDBK cells
transfected with the transcribed RNA of both clones at 24 h
post-transfection by the IFA assay. The transfection resulted
in efﬁcient virus recovery for both clones, with a mean P0
titer of 104.5 plaque-forming units (PFU)/mL at 72 h after the
transfection (data not shown). The viruses recovered from the
transfected cell cultures were named chi-NADL/IBSP4ncp#2
and chi-NADL/IBSP4ncp#3. To conﬁrm the presence of infec-
tious progeny viruses, the supernatants collected from these
cultures were inoculated to fresh MDBK cells, followed by
the IFA assay for viral antigens 72 h later (data not shown).
The stability of the chi-NADL/IBSP4ncp#2 and #3 viruses in
MDBK cells was conﬁrmed during 10 passages (Fig. 2A). At
all tested passages, the viruses reached titers of approx-
imately 105.5–6.0 PFU/mL at 72 h post-infection (data not
shown).
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Fig. 2 – Infectivity of recombinant viruses. (A) IFA for viral antigens. Negative control: mock-infected MDBK cells; positive
control: MDBK cells inoculated with the parental strain; chi-NADL/IBSP4ncp #2 and #3 virus. And the same viruses (# 2 and
3) recovered from plasmid DNA ampliﬁed in E. coli (p5). (B) IPX for viral antigens. Morphology of infectious foci produced in
MDBK cells by viruses rescued at p5. (C) Replication curve of viruses recovered at p5 and parental virus. MDBK cells were
inoculated with the respective viruses at an MOI  of 0.3 and supernatants collected at different intervals were  submitted to
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eplication  kinetics,  focus  size,  and  morphology
onﬂuent MDBK monolayers were inoculated with each virus
t an MOI  of 0.3, and the culture supernatants collected
t different intervals were titrated for viruses. Both chi-
ADL/IBSP4ncp#2 and #3 replicated to similar levels, and
he kinetics was indistinguishable from that of the parental
train (Fig. 2C). Then, we  investigated using IPX staining
he morphology and size of the plaques/foci produced on
DBK cells by chi-NADL/IBSP4ncp#2 and #3 at p5 and com-
ared the features with those of the parental strain. The
ize and morphology of the infectious foci produced by chi-
ADL/IBSP4ncp#2 and #3 were indistinguishable from those
f the foci produced by the parental virus (Fig. 2B).enome  sequencing
e  chose one clone (chi-NADL/IBSP4ncp#2) to investigate
or possible mutations in the viral genome. At p0, one silent
Table 2 – Analysis of sequences of the virus recovered from the
Localization Nucleotidea IBSP4ncp Chi-NADL/IBSP4ncp#2 passage
Npro 439 T C 
Npro 463 C C 
Npro 499 G G 
Npro 514 A A 
Npro 550 A A 
E1 2295 A Cb
NS5B 12,079 G G 
a Nucleotide and amino acids positions correspond to those of the publish
b This nucleotide change reverted to the original at passage 5.o independent experiments.
mutation was detected in the Npro gene, and another muta-
tion was detected in the E1 gene, but the latter reverted to the
original nucleotide at p5. At p5, a few additional mutations
were detected in the ﬁrst ORF-encoded protein, Npro. Among
those, three single-nucleotide changes (nt 463, 499, and 514)
did not result in amino acid changes, while one resulted in
a substitution by an amino acid from the same chemical
group (Glu550Asp). Besides, one mutation (Ser12079Asn) was
detected in the NS5B gene, resulting in a substitution by an
amino acid from a different chemical group. The mutations
are shown in Table 2.
Stability  of  cDNA  clones  in  E.  coli
To access the stability of the recombinant cDNA clones in
bacteria, the plasmids pBSC IBSP4ncp#2 and #3 were ampli-
ﬁed in E. coli. Plasmid DNA was extracted from the bacterium,
ampliﬁed by PCR, and used as a template for in vitro tran-
scription. The RNAs transcribed from these amplicons were
 cDNA clone and parental virus.
 0 Chi-NADL/IBSP4ncp#2 passage 5 Name or type of mutation
C Silent
T Silent
A Silent
G Silent
T Glu550Asp
A –
A Ser3898Asn
ed IBSP4ncp genome/polyprotein.
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infectious upon transfection into MDBK cells. The progeny
viruses were subjected to ﬁve passages in MDBK cells and
maintained their infectivity and replication efﬁciency (Fig. 2A).
At all tested passages, the viruses reached titers of approx-
imately 105.5–6.0 PFU/mL at 72 h post-infection (data not
shown). The stability of viral cDNA in prokaryote system is
important due to higher amount and quality of recombinant
DNA extracted from bacteria in relation to yeast, facilitating its
future use in some experiments, as such genome sequencing
and in vitro transcription.
Discussion
Full-length, chimeric cDNA clones of BVDV-1 were constructed
using the strategy of homologous recombination in yeast. The
assembled clones contained the NADL 5′ and 3′ UTRs ﬂanking
the ORF of a representative Brazilian BVDV-1 strain (IBSP4ncp).
The viruses recovered from the cells transfected with in vitro-
transcribed RNA were viable, maintained the main replicative
properties of the parental virus, and were stable over 10 pas-
sages in cell culture. A few mutations in the viral genome were
identiﬁed; nevertheless, there were no phenotypic changes in
the infectious clone in vitro. Moreover, the yeast-assembled
plasmids were ampliﬁed in E. coli, the RNA transcribed in vitro
from the bacterial plasmid DNA generated infectious viruses
upon transfection, and the resulting viruses were stable in cell
culture. Thus, the strategy of homologous recombination in
yeast seems suitable for the construction and manipulation
of pestivirus recombinant cDNA clones.
Homologous recombination in the yeast S. cerevisiae
has arisen as molecular methodology for many  applica-
tions, including the construction of cDNA clones of various
viruses. In this strategy, DNA fragments containing nucleotide
sequences homologous to the vector at their ends may be
directly cloned by in vivo recombination in the host. In this
way, multiple DNA fragments can be correctly assembled in a
unique molecule.26 This strategy has several applications and
shows advantages over traditional cloning methods. In partic-
ular, it does not depend on multiple restriction sites or the use
of many  ampliﬁcation products, unlike traditional cloning in
bacteria, as reported by Park et al.16 to construct a CSFV cDNA
clone.16 These properties make this approach easier, less labo-
rious, and more  efﬁcient than traditional cloning strategies.26
Along with other applications using viruses,24 this method-
ology has successfully been used to overcome the problems
of instability of some ﬂavivirus recombinant cDNA genomes
in E. coli.20,27 A prerequisite for homologous recombination
in yeast is the presence of nucleotide sequence homology
(15–50 bp) at the ends of the DNA fragments and the vector
to be recombined, necessary to recruit the yeast recombina-
tion machinery.28,29 In our system, homologous sequences of
25 bp in both UTRs at the ends of fragments 1 and 3 were
shown to sufﬁce to direct recombination in the yeast. The
ﬂexibility in terms of the size of cloned fragments, the length
of homologous sequences, and the use of intrinsic restriction
sites presents obvious advantages of this cloning strategy, sim-
plifying the procedures. Also, there is no need to purchase
cloning kits used for conventional cloning strategies. b i o l o g y 4 7 (2 0 1 6) 993–999
The rescued viruses were stable over 10 passages in cell
culture, maintaining the replication efﬁciency and kinetics,
focus size, and morphology of the parental virus. The stability
in cell culture achieved by our system was better than BAC
system for some pestiviruses, although this technique has
been used to reduce the instability of cDNA clones.17 Thus,
neither the genetic manipulation nor the presence of the het-
erologous UTRs adversely affected the replication properties
of the rescued viruses or altered their main phenotypic prop-
erties in vitro. The NADL UTR sequences were used in the
construct since the corresponding IBSP4ncp sequences were
unknown at the time when we assembled the cDNA clones.
A similar strategy was described earlier, in one study parts of
the CP7 5′ and 3′ UTRs were replaced by parts of the respec-
tive NADL UTRs10 and Hoffmann30 creates an interspecies
cDNA clone with BVDV UTRs plus CSFV ORF,  both viruses
replicated efﬁciently.10,30 The heterologous UTRs present in
our construct may serve as genetic markers, conﬁrming the
recombinant origin and helping avoid potential contami-
nations with the parental virus. Anyway, the viability and
replication efﬁciency of the rescued viruses show the promise
of this methodology for generating recombinant BVDV.
Nucleotide sequencing of the rescued virus chi-
NADL/IBSP4ncp#2 at p0, revealed one silent mutation in
the Npro gene, which was still detected at p5. Another
mutation was detected in the E1 gene at p0 but reverted
to the original nucleotide at p5 (Table 2). At p5, mutations
were mainly found in the ﬁrst ORF-encoded protein, Npro
(Table 2). Three nucleotide changes (nt 463, 499, and 514)
did not result in amino acid substitutions. However, two
nucleotides changes in the NS5B gene resulted in amino
acids substitution: one by an amino acid from the same
chemical group (Glu550Asp) and other by an amino acid from
a different chemical group (Ser12079Asn) (Table 2). However,
as mentioned above, no obvious phenotypic changes were
observed in the rescued viruses in cell culture, compared
to the parental strain. Park et al.16 recently constructed, a
cDNA clone using standard techniques and obtained similar
mutations rates, nevertheless the phenotype of the rescued
virus showed lower levels of replication. No mutation was
found in the original plasmids or in the PCR products used as
templates for in vitro transcription in our study. Since certain
DNA manipulations would require higher amounts of DNA,
we also investigated the stability of the yeast-assembled
DNA plasmids in E. coli. The successful recovery of infectious
viruses that were stable in cell culture over ﬁve passages from
the RNA transcribed from the plasmids replicated in E. coli
demonstrated that these plasmids were stable and, therefore,
may be ampliﬁed and maintained in this host.
In summary, the recombinant viruses reported herein,
chimeric in their UTRs, contain the entire ORF of the Brazil-
ian BVDV strain IBSP4ncp and retain its protein and antigenic
properties. IBSP4ncp was demonstrated to display a high
degree of serological cross-reactivity with a wide range of
Brazilian BVDV isolates21 and, therefore, is considered to be
a representative strain and a candidate for vaccine devel-
opment. Thus, in the future, a recombinant derivative of
IBSP4ncp can be used as a backbone to generate recombinant
vaccine clones, due to its high antigenic similarity to Brazilian
ﬁeld isolates.
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